ADVERSE DRUG EVENT REPORTING OF REMDESIVIR
Author(s):
Gawali Vijay Appu, Dipak A. Joshi, Shyamlila B. Bavage, Nandkishor B. Bavage
Keywords:
Abstract
Purpose; Remdesivir shows promise in the treatment of COVID19 patients. Despite this, it is still necessary to record potential drug side effects (PBL) for future decision-making. Same as the limited ADE data available before the COVID19 pandemic.
Article Details
Unique Paper ID: 152387

Publication Volume & Issue: Volume 8, Issue 3

Page(s): 159 - 161
Article Preview & Download


Share This Article

Conference Alert

NCSST-2023

AICTE Sponsored National Conference on Smart Systems and Technologies

Last Date: 25th November 2023

SWEC- Management

LATEST INNOVATION’S AND FUTURE TRENDS IN MANAGEMENT

Last Date: 7th November 2023

Go To Issue



Call For Paper

Volume 10 Issue 1

Last Date for paper submitting for March Issue is 25 June 2023

About Us

IJIRT.org enables door in research by providing high quality research articles in open access market.

Send us any query related to your research on editor@ijirt.org

Social Media

Google Verified Reviews